T1	Pharmacological_substance 36 52	arsenic trioxide
N1000 	Reference T1 MeSH:C006632	arsenic trioxide
T3	Disorder 71 125	ATRA-resistant relapse of acute promyelocytic leukemia
T4	Pharmacological_substance 128 144	Arsenic trioxide
N1001 	Reference T4 MeSH:C006632	Arsenic trioxide
T5	Disorder 219 247	acute promyelocytic leukemia
N1 	Reference T5 UMLS:C0023487	acute promyelocytic leukemia
T6	Pharmacological_substance 277 293	arsenic trioxide
N1002 	Reference T6 MeSH:C006632	arsenic trioxide
T8	Pharmacological_substance 497 513	arsenic trioxide
N1003 	Reference T8 MeSH:C006632	arsenic trioxide
T9	Disorder 800 812	leukocytosis
N2 	Reference T9 UMLS:C0023518	leukocytosis
T13	Pharmacological_substance 1134 1150	arsenic trioxide
N1004 	Reference T13 MeSH:C006632	arsenic trioxide
T18	Subject 333 361	a 56-year-old female patient
T19	Disorder 390 408	ATRA-resistant APL
T20	Subject 56 65	a patient
T7	Disorder 1154 1176	relapsed/resistant APL
T12	Disorder 249 252	APL
N3 	Reference T12 UMLS:C0023487	APL
T25	Disorder 453 470	elevated D-dimers
N4 	Reference T25 UMLS:C0742969	elevated D-dimers
T26	Disorder 1032 1060	PML-RAR alpha fusion product
T29	Disorder 419 429	APL blasts
